Heidi Henson serves as Executive at LISATA THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Heidi Henson has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 9, 2026 involved receiving (via award) 30,456 shares valued at $0.
Heidi Henson currently holds 85,725 shares of LISATA THERAPEUTICS, INC. (LSTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Heidi Henson has been a net neutral trader of LSTA stock. They have purchased $0 and sold $0 worth of shares.
Heidi Henson's most recent insider trade was on Jan 9, 2026, when they sold 30,456 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 31, 2023 | PRDS | $0 | Tender | 316,753 | $N/A | Discretionary |
| Jan 9, 2023 | LSTA | $0 | Award | 20,000 | $N/A | Discretionary |